Annual Accounts Receivable
$31.50 M
+$31.50 M+100.00%
December 31, 2024
Summary
- As of March 13, 2025, VRNA annual accounts receivable is $31.50 million, with the most recent change of +$31.50 million (+100.00%) on December 31, 2024.
- VRNA annual accounts receivable is now at all-time high.
Performance
VRNA Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$31.50 M
+$24.59 M+356.20%
December 31, 2024
Summary
- As of March 13, 2025, VRNA quarterly accounts receivable is $31.50 million, with the most recent change of +$24.59 million (+356.20%) on December 31, 2024.
- Over the past year, VRNA quarterly accounts receivable has increased by +$31.50 million (+100.00%).
- VRNA quarterly accounts receivable is now at all-time high.
Performance
VRNA Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
VRNA Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | +100.0% |
| 3 y3 years | - | +100.0% |
| 5 y5 years | - | +100.0% |
VRNA Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | at high | -100.0% |
| 5 y | 5-year | at high | -100.0% | at high | -100.0% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Verona Pharma Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $31.50 M(>+9900.0%) | $31.50 M(+356.2%) |
| Sep 2024 | - | $6.90 M(>+9900.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(-100.0%) |
| Jun 2021 | - | $25.00 M(+8234.0%) |
| Jun 2012 | - | $300.00 K(-7.6%) |
| Jun 2011 | - | $324.70 K(+651.6%) |
| Dec 2010 | $43.20 K(-91.8%) | $43.20 K(-63.2%) |
| Jun 2010 | - | $117.40 K(-77.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $525.50 K(+1181.7%) | $525.50 K(+383.9%) |
| Jun 2009 | - | $108.60 K(+164.9%) |
| Dec 2008 | $41.00 K(-89.5%) | $41.00 K(-77.8%) |
| Jun 2008 | - | $185.10 K(-52.4%) |
| Dec 2007 | $388.70 K(+891.6%) | $388.70 K(+84.3%) |
| Jun 2007 | - | $210.90 K(+438.0%) |
| Dec 2006 | $39.20 K(+1052.9%) | $39.20 K(+1052.9%) |
| Dec 2005 | $3400.00 | $3400.00(-5.6%) |
| Jun 2005 | - | $3600.00 |
FAQ
- What is Verona Pharma annual accounts receivable?
- What is the all time high annual accounts receivable for Verona Pharma?
- What is Verona Pharma annual accounts receivable year-on-year change?
- What is Verona Pharma quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Verona Pharma?
- What is Verona Pharma quarterly accounts receivable year-on-year change?
What is Verona Pharma annual accounts receivable?
The current annual accounts receivable of VRNA is $31.50 M
What is the all time high annual accounts receivable for Verona Pharma?
Verona Pharma all-time high annual accounts receivable is $31.50 M
What is Verona Pharma annual accounts receivable year-on-year change?
Over the past year, VRNA annual accounts receivable has changed by +$31.50 M (+100.00%)
What is Verona Pharma quarterly accounts receivable?
The current quarterly accounts receivable of VRNA is $31.50 M
What is the all time high quarterly accounts receivable for Verona Pharma?
Verona Pharma all-time high quarterly accounts receivable is $31.50 M
What is Verona Pharma quarterly accounts receivable year-on-year change?
Over the past year, VRNA quarterly accounts receivable has changed by +$31.50 M (+100.00%)